The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Open accessAbstract
Perturbations in the intestinal microbiome are strongly linked to the pathogenesis of inflammatory bowel disease (IBD). Bacteria, fungi and viruses all make up part of a complex multi-kingdom community colonizing the gastrointestinal tract, often referred to as the gut microbiome. They can exert various effects on the host that can contribute to an inflammatory state. Advances in screening, multiomics and experimental approaches have revealed insights into host-microbiota interactions in IBD and have identified numerous mechanisms through which the microbiota and its metabolites can exert a major influence on the gastrointestinal tract. Looking into the future, the microbiome and microbiota-associated processes will be likely to provide unparalleled opportunities for novel diagnostic, therapeutic and diet-inspired solutions for the management of IBD through harnessing rationally designed microbial communities, powerful bacterial and fungal metabolites, individually or in combination, to foster intestinal health. In this Review, we examine the current understanding of the cross-kingdom gut microbiome in IBD, focusing on bacterial and fungal components and metabolites. We examine therapeutic and diagnostic opportunities, the microbial metabolism, immunity, neuroimmunology and microbiome-inspired interventions to link mechanisms of disease and identify novel research and therapeutic opportunities for IBD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammatory bowel disease (IBD) is marked by surges of pro-inflammatory Veillonellaceae and Proteobacteria and a concomitant loss of SCFA producers like Ruminococcus bromii, Bifidobacterium spp., and F. prausnitzii.110”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [110]
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Gut mycobiome composition is highly variable between and within individuals, as diet and environmental exposure (Box 1) change constantly 51,52 .”
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614 · cited 1×
“Spore-forming bacteria from both mice and humans can promote biosynthesis of serotonin from colonic enterochromaffin cells through release of metabolites, indicating that they are modulators of gut serotonin levels 153 .”
Cited by
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Yang, X., Guo, H., & Zou, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00395-z · Cited by 92
AI-empowered human microbiome research
Tian, Z., & Zhao, F. (2025) · Gut · doi:10.1136/gutjnl-2025-335946 · Cited by 78
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
Wu, Z., Wu, Q., Han, Y., Xiang, S.-J., Wang, Y., Wu, W.-W., Chen, Y., Feng, Z., Wang, Y.-Y., Xu, Z.-G., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.002 · Cited by 49
Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes
Zhang, L., Marfil-Sánchez, A., Kuo, T.-H., Seelbinder, B., van Dam, L., Depetris-Chauvin, A., Jahn, L. J., Sommer, M. O. A., Zimmermann, M., Ni, Y., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02197-z · Cited by 31
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
Metadata
- Authors
- Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J.
- Affiliations
- Cornell University (US)
- Harvard University (US)
- Corresponding author
- Iliev, Iliyan D.
- Venue
- Nature Reviews Microbiology
- Published
- 2025-03-10
- Volume
- 23
- Issue
- 8
- Pages
- 509-524
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC12289240
- OpenAlex
- W4408295662
- Cited by
- 249
- References
- 210
- Citations by year
- 2026: 183 · 2025: 66
- FWCI
- 22.04
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-03-24)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA286920)
- National Institute of Allergy and Infectious Diseases (R01AI178683, R01AI172027, R01AI163007)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121977, R01DK132244, R01DK135816, R01DK113136)
- National Center for Complementary and Integrative Health (R01AT013241)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, gut microbiota, host-microbiota interactions, bacterial metabolites, fungal metabolites, microbial metabolites, intestinal immunity, neuroimmunology, enteric nervous system, microbiota-based therapy, microbiome diagnostics, diet and microbiome
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Fungi, Humans, Inflammatory Bowel Diseases, Gastrointestinal Tract, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. https://app.cochat.ai/papers/10.1038/s41579-025-01163-0
- The paper
- Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J. (2025). Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-025-01163-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.